Michael Charness

@VABostonHC, @harvardmed, @BUMedicine, @BrighamWomens Neurologist/neuroscientist. Views my own

[Michael Charness @CharnessMichael]

@ABC Age Karen Antman dean bu

[Michael Charness @CharnessMichael]

We showed that genetically identical SARS-CoV-2 infected two patients who were admitted to a hospital room 1 hour, 43 minutes and 4 hours, 45 minutes after discharge of an asymptomatic infected patient. (3/3)

[Michael Charness @CharnessMichael]

How long is airborne SARS-CoV-2 infectious after an infected person leaves the room? Our new preprint suggests nearly 5 hours. https://t.co/mrAsqfdKKP
@PaulSaxMD @linseymarr @EricTopol (1/3)

[Michael Charness @CharnessMichael]

The half-life for survival of SARS-CoV-2 in aerosols is 1-3 hours based on the ability to culture virus in cells. However, it is less clear how long airborne SARS-CoV-2 remains capable of infecting people. (2/3)

[Samantha Connolly, PhD @Sam_L_Connolly]

🚨New pub w/ @CharnessMichael @allenlgifford @christojoe1979!
We found differences btwn psychologist + psychiatrist attitudes towards video + phone #telehealth. Psychiatrists had⬆️phone use & report more video challenges.
@VA_CHOIR @va_vccore @APA_Journals
https://t.co/u7tWrMv56B

[Michael Charness @CharnessMichael]

As we begin to shed masks in medical centers, preventing SP will become more important.(9/9)

[Michael Charness @CharnessMichael]

Happy to share our paper on sickness presenteeism (SP) in healthcare workers (HCW) with COVID. https://t.co/9YE21WTatZ )(1/9)@EricTopol @MonicaGandhi9 @PaulSaxMD

[Michael Charness @CharnessMichael]

Identification of SP was 3-fold higher in HCW under surveillance on high-risk units; active surveillance might mitigate the risk of transmission related to SP.(8/9)

[Judith Strymish @JudithStrymish]

Congratulations K Gupta @kmfitani1 bill obrien! @CharnessMichael @tony_breu @rbganatra @mvronan @wbranchelliman Covid does not increase surgical risk. https://t.co/XQT84ZzLQF

[Nature Reviews Disease Primers @DiseasePrimers]

Our NEW Primer on Fetal alcohol spectrum disorders is live today! By Popova, @CharnessMichael, Burd, @DrAndiCrawford, Hoyme, @rajamukherjee10, Riley and @ProfEElliott. #FASD

Check it out here: https://t.co/MVw8U4tswQ

[Michael Charness @CharnessMichael]

Happy to share our review of fetal alcohol spectrum disorders (FASD). FASD is a common cause of cognitive and behavioral disabilities and medical disorders in children and adults. https://t.co/lwvWx4QGus @FASDUnited @GlobeKayLazar @benryanwrite @ReporterGoodman @NIAAAnews

[Michael Charness @CharnessMichael]

@MonicaGandhi9 @LizHighleyman @Slate Cochrane review was a small number of imperfect RCTs with little ability to test source control. Data more compelling in healthcare settings where more universal masking occurs.

[Michael Charness @CharnessMichael]

@EricTopol @SutharLab Assay for two monovalent boosters was 70-100 days post vacc; bivalent 16-42 days post vacc. Difference in neutralizing antibodies could be from waning immunity after two monovalent boosters. More time needed to compare bivalent and monovalent booster after similar lag time.

[Michael Charness @CharnessMichael]

@pbaker @PaulSaxMD @michaelmina_lab @AshishKJha46 New NBA data show 0.7% incidence of rebound without antiviral rx. Together, the new studies suggest Paxlovid and Molnupiravir increase rebound by ~8 and 12-fold, respectively, https://t.co/Jl0rbv71hh
@Bob_Wachter @EricTopol @GlobeKayLazar @ReporterGoodman

[Michael Charness @CharnessMichael]

#paxlovidrebound
-Updated our Paxlovid rebound preprint, which now includes 10 cases.
-Two cases of transmission during rebound, including one while presymptomatic on Day 12
https://t.co/e9ZomhnvtY
@PaulSaxMD @michaelmina_lab @AshishKJha46